WuXi AppTec acquires OXGENE to strengthen cell and gene therapy offerings
WuXi AppTec, a Shanghai, China-headquartered global provider of R&D- and manufacturingenabling services in the pharmaceutical, biotechnology and medical device industries, has acquired OXGENE, a pioneering United Kingdom-based contract research and development organization that designs and develops scalable gene therapy technologies. This acquisition enables WuXi AppTec to offer its customers end-to-end support in the creation and […]
